Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 8/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.59 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.59 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.59 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.59 |
| ▸ | FABP3 | P05413 | 5/20 | 0.57 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28058163 | 1.00 | LPAR1 (0.59) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| SCHEMBL28182447 | 1.00 | LPAR1 (0.59) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| SCHEMBL4981342 | 0.98 | LPAR1 (0.60) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| SCHEMBL27470122 | 0.98 | LPAR1 (0.60) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| SCHEMBL193956 | 0.98 | LPAR1 (0.60) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| SCHEMBL22802118 | 0.98 | LPAR1 (0.60) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| SCHEMBL18123890 | 0.98 | LPAR1 (0.60) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| SCHEMBL193957 | 0.98 | LPAR1 (0.60) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| SCHEMBL28505493 | 0.97 | LPAR1 (0.59) | LPAR1ENPP2LPAR2LPAR4LPAR5 | |
| Ammonia Solution, Strong SCHEMBL7121875 | 0.97 | LPAR1 (0.59) | LPAR1ENPP2LPAR2LPAR4LPAR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2229156-A1 | CHEWING GUM TABLET AND METHOD OF DOSING PHARMACEUTICALLY ACTIVE INGREDIENTS IN SUCH CHEWING GUM TABLET | Fertin Pharma A/S (DK) | 2010-09-22 | — | — | EP | claimed |
| EP-2229157-A1 | COMPRESSED CHEWING GUM TABLET | Fertin Pharma A/S (DK) | 2010-09-22 | — | — | EP | claimed |
| EP-2229158-A1 | COMPRESSED CHEWING GUM TABLET | Fertin Pharma A/S (DK) | 2010-09-22 | — | — | EP | claimed |
| WO-2009080022-A1 | COMPRESSED CHEWING GUM TABLET | FERTIN PHARMA A/S (DK) | 2009-07-02 | — | — | WO | claimed |
| WO-2009080020-A1 | CHEWING GUM TABLET AND METHOD OF DOSING PHARMACEUTICALLY ACTIVE INGREDIENTS IN SUCH CHEWING GUM TABLET | FERTIN PHARMA A/S (DK) | 2009-07-02 | — | — | WO | claimed |
| WO-2009080021-A1 | COMPRESSED CHEWING GUM TABLET | FERTIN PHARMA A/S (DK) | 2009-07-02 | — | — | WO | claimed |
| JP-8165224-A | — | — | None | — | — | JP | disclosed |
| US-12582153-B2 | Oral formulations of kava and nicotine | ROSS JERRY WAYNE (US) | 2026-03-24 | — | — | US | disclosed |
| WO-2025245170-A1 | ORAL FORMULATIONS OF KAVA | ROSS JERRY WAYNE (US) | 2025-11-27 | — | — | WO | disclosed |
| US-20250351863-A1 | Oral Formulations of Kava | ROSS JERRY WAYNE (US) | 2025-11-20 | — | — | US | disclosed |
| US-20250351862-A1 | Oral Formulations of Kava and Nicotine | ROSS JERRY WAYNE (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4646206-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEARING DISORDERS | Gateway Biotechnology, Inc. (US) | 2025-11-12 | — | — | EP | disclosed |
| EP-3641726-B1 | CANNABINOID POUCH | NORDICCAN AS (DK) | 2025-11-05 | — | — | EP | disclosed |
| US-4879197-A | ANTIFOGGING AGENTS | MITSUBISHI PAPER MILLS, LTD. (JP) | 1989-11-07 | — | — | US | disclosed |
| EP-0286427-A2 | Recording medium | CANON KABUSHIKI KAISHA (JP) | 1988-10-12 | — | — | EP | disclosed |
| US-4707292-A | ANIONIC SURFACTANTS, SHAMPOO | KAO CORPORATION (JP) | 1987-11-17 | — | — | US | disclosed |
| US-4680235-A | Recording material for ink jet printing | RICOH COMPANY, LTD. (JP) | 1987-07-14 | — | — | US | disclosed |
| US-4197347-A | High density magnetic recording media | FUJI PHOTO FILM CO., LTD. (JP) | 1980-04-08 | — | — | US | disclosed |
| US-4128483-A | Sulfur-containing complex esters and spin finishing compositions using said esters | NIPPON OIL AND FATS CO. LTD. (JP) | 1978-12-05 | — | — | US | disclosed |
| US-4063000-A | Process for production of ferromagnetic powder | FUJI PHOTO FILM CO., LTD. (JA) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582153-B2 | Oral formulations of kava and nicotine | PDK2, PDHA1, LDHA | LPAR1 3908/4885ENPP2 4770/4885LPAR2 3048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.